Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioMarin Pharmaceuticals, Inc. (NQ: BMRN)
65.76 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about BioMarin Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Uptrend Call Working As BioMarin Pharmaceutical Stock Rises 34.8% (BMRN)
May 23, 2013
from Comtex SmarTrend® News Briefs
Cramer's Watch List Ahead of Big Cancer Conference
May 20, 2013
The American Society of Clinical Oncology meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer. Read More
category BioMarin Pharmaceutical Inc , Biotechnology , Merck & Co Inc , and 13 more.
from CNBC.com News
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8340860 for the full story. Read More
from StreetInsider.com News Articles
Recent 52-Week High Exceeded in Shares of BioMarin Pharmaceutical (BMRN)
May 14, 2013
from Comtex SmarTrend® News Briefs
Today’s Research on DCTH, AKRX, ASTX, BMRN, and FRX
May 10, 2013
from ACCESSWIRE
BioMarin Pharmaceutical Has Returned 34.3% Since SmarTrend Recommendation (BMRN)
May 02, 2013
from Comtex SmarTrend® News Briefs
BioMarin Pharmaceutical Bullish Moving Average Crossover Alert (BMRN)
April 29, 2013
from Comtex SmarTrend® News Briefs
BioMarin Pharmaceuticals, Inc. (BMRN) Misses Q1 EPS by 2c
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8280327 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 04/25: Exxon, (XOM), Dow (DOW), 3M (MMM), Hershey (HSY), UPS (UPS), Expedia (EXPE) Report
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8276525 for the full story. Read More
from StreetInsider.com News Articles
BioMarin Pharmaceutical: 52-Week High Recently Eclipsed (BMRN)
April 23, 2013
from Comtex SmarTrend® News Briefs
The Coming Boom in Healthcare M&A
April 22, 2013
The pace of mergers and acquisitions in the healthcare space is set to rise in the coming years, in part because healthcare reform actually encourages it. Read More
from Update Content Feed for Financial Content
BioMarin Pharmaceutical Inc. Moves Up In Market Cap Rank, Passing Juniper Networks Inc
April 19, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component BioMarin Pharmaceutical Inc. (BMRN) was identified as having a larger market cap than the smaller end of... Read More
category Stocks
from Market News Video
BioMarin Pharmaceutical Crosses Below its 10-day MA (BMRN)
April 18, 2013
from Comtex SmarTrend® News Briefs
Short Interest Moves 62% Lower For BMRN
April 10, 2013
The most recent short interest data has been released by the NASDAQ for the 03/28/2013 settlement date, which shows a 7,437,778 share decrease in total short interest for BioMarin Pharmaceutical Inc.... Read More
category Stocks
from Market News Video
32.8% Return Seen to Date on SmarTrend BioMarin Pharmaceutical Call (BMRN)
April 10, 2013
from Comtex SmarTrend® News Briefs
BioMarin Pharmaceutical Has Returned 31.9% Since SmarTrend Recommendation (BMRN)
April 03, 2013
from Comtex SmarTrend® News Briefs
Alexion (ALXN), BioMarin (BMRN) Could Offer Treatment for Sick Portfolio - Cramer
April 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8224139 for the full story. Read More
from StreetInsider.com News Articles
Cramer: Small Drug Stocks with Promising Pipelines
April 01, 2013
If you're looking for a small stock with big return potential, Jim Cramer thinks you should consider this. Read More
category BioMarin Pharmaceutical Inc , Biotechnology , Mad Money for Mobile , and 10 more.
from CNBC.com News
BioMarin Pharmaceutical: The Winning Streak Continues (BMRN)
April 01, 2013
from Comtex SmarTrend® News Briefs
BioMarin (BMRN) Submits CTA for BMN-190 to U.K.'s MHRA
April 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8220897 for the full story. Read More
from StreetInsider.com News Articles
BioMarin (BMRN) Submits BLA for Vimizim to FDA
April 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8220885 for the full story. Read More
from StreetInsider.com News Articles
BioMarin Pharmaceutical Up 25.5% Since SmarTrend Uptrend Call (BMRN)
March 27, 2013
from Comtex SmarTrend® News Briefs
Biomarin Closes Added Partial Exchange of Convertible Notes Due 2017
March 25, 2013
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that an additional six holders of its 1.875% Convertible Senior Subordinated Notes due 2017 have agreed to exchange $75.8 million in... Read More
category Benzinga , BMRN , Offerings , and 1 more.
from Latest Articles from Benzinga.com
Get out of junk stocks now
March 22, 2013
Because the Federal Reserve’s easy-money policies won’t continue indefinitely, investors might want to begin reducing their holdings of low-quality stocks — which will be among the biggest casualties... Read More
category Retail , Opinion , KO , and 11 more.
from MarketWatch
BioMarin's BMN-701 has 60% Probability of Success, Says Analyst
March 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8200739 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Piper Jaffray Raises PT on BioMarin Pharmaceutical on Positive Trial Results
March 20, 2013
In a report published Wednesday, Piper Jaffray analyst M Ian Somaiya reiterated an Overweight rating on BioMarin Pharmaceutical (NASDAQ: BMRN ), and raised the price target from $64.00 to $70.00. In... Read More
category Benzinga , Piper Jaffray , BMRN , and 3 more.
from Latest Articles from Benzinga.com
Uptrend Call Working As BioMarin Pharmaceutical Stock Rises 27.2% (BMRN)
March 19, 2013
from Comtex SmarTrend® News Briefs
BioMarin to Advance BMN-701 for Pompe Disease to Next Phase of Trials, Sees Phase 2/3 Switching Trial by End of 2013
March 19, 2013
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today results from POM-001, the Phase 1/2 trial for BMN-701, a fusion protein of insulin-like growth factor 2 and acid alpha-glucosidase... Read More
category Benzinga , BMRN , News , and 1 more.
from Latest Articles from Benzinga.com
BioMarin Pharmaceutical Crosses Above its 10-day MA (BMRN)
March 18, 2013
from Comtex SmarTrend® News Briefs
Cramer: 8 Top Performers Over Last 8 Years
March 15, 2013
Who says you can't beat the market. Had you picked stocks thoughtfully and carefully, since Mad Money began, you could have beaten the S&P by 3000%! Read More
category Regeneron Pharmaceuticals Inc , CRM Holdings Ltd/ , BioMarin Pharmaceutical Inc , and 23 more.
from CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here